Krebs Biochemicals & Industries (BOM:524518) Total Liabilities : ₹2,973.9 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Total Liabilities?

Krebs Biochemicals & Industries's Total Liabilities for the quarter that ended in Mar. 2024 was ₹2,973.9 Mil.

Krebs Biochemicals & Industries's quarterly Total Liabilities declined from Sep. 2023 (₹2,864.94 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹2,973.91 Mil).

Krebs Biochemicals & Industries's annual Total Liabilities increased from Mar. 2022 (₹2,648.99 Mil) to Mar. 2023 (₹2,744.44 Mil) and increased from Mar. 2023 (₹2,744.44 Mil) to Mar. 2024 (₹2,973.91 Mil).

Krebs Biochemicals & Industries Total Liabilities Historical Data

The historical data trend for Krebs Biochemicals & Industries's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries Total Liabilities Chart

Krebs Biochemicals & Industries Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

1,587.96

2,019.53

2,648.99

2,744.44

2,973.91

Krebs Biochemicals & Industries Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															2,744.44	-	2,864.94	-	2,973.91

Krebs Biochemicals & Industries Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Krebs Biochemicals & Industries's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	618.339	+	(1835	+	495.014
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	25.561)
	=	2,973.9

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	1781.747	-	-1192.167
	=	2,973.9

Krebs Biochemicals & Industries's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	618.339	+	(1835	+	495.014
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	25.561)
	=	2,973.9

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1781.747	-	-1192.167
	=	2,973.9

Krebs Biochemicals & Industries Total Liabilities Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Krebs Biochemicals & Industries (BOM:524518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Total Liabilities

Traded in Other Exchanges

KREBSBIO:India

Address

Road No. 8, Banjara Hills, 8-2-577/B, Plot No. 34, 3rd Floor, Maas Heights, Hyderabad, TG, IND, 500 034

Website

http://www.krebsbiochem.com

Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries (BOM:524518) Headlines

No Headlines